» Authors » Somashekar G Krishna

Somashekar G Krishna

Explore the profile of Somashekar G Krishna including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 201
Citations 1735
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Jain A, Gokun Y, Hart P, Ramsey M, Papachristou G, Han S, et al.
Pancreatology . 2025 Feb; PMID: 40021427
Background/objectives: Cholelithiasis is the most common cause of acute pancreatitis in pregnancy. We analyzed trends in acute biliary pancreatitis (ABP) among pregnant women over the past two decades to evaluate...
2.
Ramsey M, Lu A, Gumpper-Fedus K, Culp S, Bradley D, Conwell D, et al.
BMC Gastroenterol . 2025 Feb; 25(1):60. PMID: 39915752
Background: Sarcopenia is common in chronic pancreatitis (CP) and has been associated with unfavorable outcomes; however, it is not well studied in acute pancreatitis (AP). Aims: To evaluate risk factors...
3.
Abdelbaki A, Hawa F, Krishna S
Gastroenterology . 2025 Feb; PMID: 39894283
No abstract available.
4.
Underwood P, Leuschner T, Ejaz A, Dillhoff M, Tsai S, Pawlik T, et al.
J Am Coll Surg . 2025 Jan; PMID: 39803957
Background: Neoadjuvant therapy (NT) is increasingly utilized for patients with pancreatic ductal adenocarcinoma (PDAC). Disease progression, toxicity, and failure to undergo surgical resection are common during NT, yet little research...
5.
Park M, Gumpper-Fedus K, Krishna S, Genilo-Delgado M, Brantley S, Hart P, et al.
Int J Mol Sci . 2024 Dec; 25(23). PMID: 39684873
Intraductal papillary mucinous neoplasms (IPMN) are commonly detected pancreatic cysts that may transform into pancreatic ductal adenocarcinoma (PDAC). Predicting which IPMNs will progress to PDAC remains a clinical challenge. Moreover,...
6.
Bejjani J, Culp S, Nikahd M, Evans Phillips A, Singh V, Roberts K, et al.
Clin Transl Gastroenterol . 2024 Dec; 16(2):e00799. PMID: 39679584
Introduction: Gastrointestinal (GI) symptoms and weight loss develop during and after acute pancreatitis (AP), but remain understudied. In this prospective, multicenter study, we aim to assess GI symptom burden and...
7.
8.
Cloyd J, Sarna A, Arango M, Bates S, Bhutani M, Bloomston M, et al.
JAMA Surg . 2024 Dec; 160(2):172-180. PMID: 39630427
Importance: Neoadjuvant therapy (NT) is an increasingly used treatment strategy for patients with localized pancreatic ductal adenocarcinoma (PDAC). Little research has been conducted on cancer care delivery during NT, and...
9.
Leupold M, Chen W, Esnakula A, Frankel W, Culp S, Hart P, et al.
Gastrointest Endosc . 2024 Nov; PMID: 39557199
Background And Aims: Interobserver agreement (IOA) among pancreaticobiliary (PB) pathologists in evaluating high-grade dysplasia and/or invasive carcinoma (HGD-IC) of IPMNs remains understudied. EUS-guided needle-based confocal endomicroscopy (nCLE) can evaluate papillary...
10.
Jiang J, Krishna S
Gland Surg . 2024 Oct; 13(9):1659-1661. PMID: 39421055
No abstract available.